<html>
<head>PUBMED IDs for NOLA2</head>
<body bgcolor='#C5F0F2'><h1>NOLA2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15889794/'>[The NOLA2 and RPS3A genes as highly informative markers for human squamous cell lung cancer].</a> May 14  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18535662/'>Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis.</a> June 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20127035/'>Expression profile of significant immortalization genes in colon cancer.</a> April 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21731055/'>Worldwide genetic structure in 37 genes important in telomere biology.</a> May 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21730982/'>EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.</a> September 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21730979/'>Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines.</a> September 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21730978/'>KRAS mutations detected by the amplification refractory mutation system-Scorpion assays strongly correlate with therapeutic effect of cetuximab.</a> September 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21730976/'>Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells.</a> September 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21730974/'>Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma.</a> September 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23352883/'>[Dyskeratosis congenita: an update].</a> August 27  2013<br></body></html>
